Document is current
Any future updates will be listed below
-
Authors
Zeng, Wentao
Li, Fei
Jin, Shikai
Ho, Ping-Chih
Liu, Pu-Ste
Xie, Xin http://orcid.org/0000-0002-6784-4860
-
Funding
Funding for this research was provided by:
Zhejiang Province Public Welfare Technology Application Research Project (LGF21C130001)
Shaoxing University (13012001015005)
Taiwan National Health Research Institutes (12A1-CSPP09-014)
National Science and Technology Council (111-2314-B-400-026 -MY3)
- License Information
-
More Information
Article History
Received: 20 July 2023
Accepted: 12 September 2023
First Online: 23 September 2023
Declarations
:
: Not applicable.
: All the authors approved the final version for the publication.
: P.-C. H. serves as scientific advisor for Elixiron Immunotherapeutics and co-funder for Pilatus Biosciences. The other authors declare no competing interests.
